Details of Drug Off-Target (DOT)
General Information of Drug Off-Target (DOT) (ID: OTFI7I9Z)
DOT Name | DNA gyrase subunit A (gyrA) | ||||
---|---|---|---|---|---|
Synonyms | EC 5.6.2.2 | ||||
Gene Name | gyrA | ||||
UniProt ID | |||||
3D Structure | |||||
EC Number | |||||
Pfam ID | |||||
Sequence |
MSDLAREITPINIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFAMNELGNDWN
KPYKKSARVVGDVIGKYHPHGDSAVYDTIVRLAQDFSMRYMLVDGQGNFGSVDGDSAAAM RYTEVRMARISHELLADLDKETVDWVPNYDGTEMIPAVMPTKVPNLLVNGSSGIAVGMAW NIPPHNLTEIVNGCLALIENGNLTIDELMTYITGPDFPTGAIINGRAGIVQAYRTGRGSV YVRAKAEVEVDDKTSRETIIIVHELPYQVNKARLIEKIAELVKEKKVEGISALRDESDKD ACRIVIEIKRGESGEIVLNNLYKHTQLQTTFGINMVALDNNQPKVMNLKDILDAFLLHRR EVVTRRTVFELRKARDRAHILEGLAVALANIDPIIELIRHSDTPADAKAKLVARGWELGN VAAMLEKAGDDAARPEWLEPEFGIREGQYFLTEQQAQAILDLRLHKLTGLEHGKILEEYQ SLLDLIAELLFILASPERLMEVIRDELLAVREQYGDERPPEISASSAEINIEDLITPEDV VVTLSHQGYVKYQPITDYEAQRRGGRGKSATRIKEENFVERLLVANTHDTILCFSTRGKV YWLKVYQLPEASRGARGRPIINLLPLEEGERITAILPVKEYADDKYVFFATADGTVKKTS LSAFSRPLSSGIRAINLKEGDELIGVDITDGSNEIMLFSDAGKVVRFNEGSAAPMQPMLM SSDDVDGDDESVIDAGNDDDGSDNGEGSESTESKGTFKGVRPMGRTAGGVRGIRLLNGDK VVSLIVPRGEGAILTATENGYGKGTALTEYPTKSRGTQGVRSIKVDEDGKVSIDQVDDTD QIMLITNGGTLVRTRVSEVSIIGRNTGGVRLIRTGEDETVVGLQRIAESYEEENDVMAID GEVSEGTDTAPDAGSAAADPEE |
||||
Function |
A type II topoisomerase that negatively supercoils closed circular double-stranded (ds) DNA in an ATP-dependent manner to modulate DNA topology and maintain chromosomes in an underwound state. Negative supercoiling favors strand separation, and DNA replication, transcription, recombination and repair, all of which involve strand separation. Also able to catalyze the interconversion of other topological isomers of dsDNA rings, including catenanes and knotted rings. Type II topoisomerases break and join 2 DNA strands simultaneously in an ATP-dependent manner.
|
||||
Molecular Interaction Atlas (MIA) of This DOT
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
This DOT Affected the Drug Response of 1 Drug(s)
|
|||||||||||||||||||||||||